Aspect Biosystems

Aspect Biosystems is a Vancouver, British Columbia biotechnology company developing Bioprinted Tissue Therapeutics — implantable, allogeneic living tissues designed to replace, repair, or supplement biological function in the body. Spun out of an interdisciplinary medicine-and-engineering collaboration at the University of British Columbia in 2013, the company operates a self-described full-stack tissue therapeutic platform that integrates proprietary AI-powered microfluidic bioprinting, computational tissue design tools, therapeutic and hypoimmune-engineered cells, and advanced biomaterials. Its clinical pipeline targets metabolic and endocrine disease, led by pancreatic tissue programs for type 1 diabetes and programs in rare endocrine disorders and liver disease. Aspect has raised more than US$350M, including a US$115M Series B, and holds partnerships with Novo Nordisk (announced 2023, valued at over US$2.6B in milestones) and the governments of Canada and British Columbia. It is a private, pre-commercial therapeutics developer: it publishes no public developer portal, API documentation, SDKs, or machine-readable API contract.

Aspect Biosystems is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Regenerative Medicine, and Bioprinting.

Aspect Biosystems’ developer surface includes product news, YouTube channel, and 11 more developer resources.

🌐 Visit website 📡 Source on GitHub

6.5/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-25 · rubric v0.14.0

0 APIs

Company Biotechnology Life Sciences Regenerative Medicine Bioprinting Tissue Engineering Cell Therapy Healthcare Canada

Kin Score

Kin Score How this is scored →
scored 2026-08-25 · rubric v0.14.0

Composite quality — 6.5/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 1.8 / 17

Operational Transparency 0.3 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Delegated User Identity 0 / 6

Protected Resource Metadata 0 / 5

Registration Without a Human 0 / 6

Agentic Commerce Surface 0 / 5

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/aspect-biosystems: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization

GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Learn 1

Tutorials, courses, talks, and written guidance

YouTube

YouTube

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 5

The organization behind the API

Website

About

Careers

News

LinkedIn

Other 2

Properties that don't map to a standard resource type

Technology

Technology

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: aspect-biosystems
name: Aspect Biosystems
description: 'Aspect Biosystems is a Vancouver, British Columbia biotechnology company developing Bioprinted Tissue Therapeutics
  — implantable, allogeneic living tissues designed to replace, repair, or supplement biological function in the body. Spun
  out of an interdisciplinary medicine-and-engineering collaboration at the University of British Columbia in 2013, the company
  operates a self-described full-stack tissue therapeutic platform that integrates proprietary AI-powered microfluidic bioprinting,
  computational tissue design tools, therapeutic and hypoimmune-engineered cells, and advanced biomaterials. Its clinical
  pipeline targets metabolic and endocrine disease, led by pancreatic tissue programs for type 1 diabetes and programs in
  rare endocrine disorders and liver disease. Aspect has raised more than US$350M, including a US$115M Series B, and holds
  partnerships with Novo Nordisk (announced 2023, valued at over US$2.6B in milestones) and the governments of Canada and
  British Columbia. It is a private, pre-commercial therapeutics developer: it publishes no public developer portal, API documentation,
  SDKs, or machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/aspect-biosystems/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.23'
created: '2026-08-02'
modified: '2026-08-02'
image: https://aspectbiosystems.com/_images/content/Tamer_Graphic_v5.svg
tags:
- Company
- Biotechnology
- Life Sciences
- Regenerative Medicine
- Bioprinting
- Tissue Engineering
- Cell Therapy
- Healthcare
- Canada
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/aspect-biosystems-domain-security.yml
- type: Website
  url: https://aspectbiosystems.com/
- type: About
  url: https://aspectbiosystems.com/about
- type: Technology
  url: https://aspectbiosystems.com/technology
- type: Contact
  url: https://aspectbiosystems.com/contact
- type: PrivacyPolicy
  url: https://aspectbiosystems.com/privacy-policy
- type: Careers
  url: https://aspectbiosystems.com/careers
- type: News
  url: https://aspectbiosystems.com/news-resources
- type: GitHubOrganization
  url: https://github.com/aspectbiosystems
- type: LinkedIn
  url: https://ca.linkedin.com/company/aspect-biosystems
- type: YouTube
  url: https://www.youtube.com/channel/UC2VA_o9ifVNxAEVoI73j8tA
- type: SecondaryMarket
  url: https://www.hiive.com/securities/aspect-biosystems-stock
- type: LLMsTxt
  url: llms/aspect-biosystems-llms.txt
x-enrichment:
  date: '2026-08-02'
  status: minimal
  artifacts_added: 3
  pass: local-v1
  contract_discovery:
    openapi: none
    swagger: none
    graphql: none
    asyncapi: none
    mcp: none
    agent_card: none
    note: Full contract discovery run 2026-08-02 against aspectbiosystems.com (the only host the company publishes; there
      is no api./docs./developer. subdomain and no baseURL or OpenAPI servers[] host to probe). /openapi.json, /swagger.json,
      /llms.txt, /.well-known/security.txt, /.well-known/openid-configuration, /.well-known/oauth-authorization-server, /.well-known/api-catalog,
      /.well-known/ai-plugin.json, /.well-known/agent-card.json and /.well-known/agent.json all return 404. The complete sitemap.xml
      contains only corporate, technology, programs, partnerships, careers, news and privacy pages — no developer, docs, or
      API section exists. The GitHub organization github.com/aspectbiosystems holds five public repositories, all forks of
      third-party tooling, with no first-party SDK or API implementation. Aspect Biosystems is a pre-commercial clinical-stage
      therapeutics developer with no public API surface. This is a valid completed pass, not a blocked one.

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this

find_providersBrowse and filter every provider in the catalog.
get_provider_artifactsEvery artifact this provider publishes, grouped by type.
get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
get_provider_ratingPRO — composite, band, trend and facet scores.
apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
resolveTurn a domain, URL or GitHub org into the provider it belongs to.
find_cohortsEvery scored population of providers in the catalog.

All 92 tools

Call it yourself

curl for this page

This provider

curl "https://apis.io/api/v1/providers/aspect-biosystems"

All providers

curl "https://apis.io/api/v1/providers?limit=25"

Every operation they expose

curl "https://apis.io/api/v1/providers/aspect-biosystems/operations?limit=25"

How their score was established

curl "https://apis.io/api/v1/providers/aspect-biosystems/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.